Vitamin A Bioavailability in Lactating Women With Marginal Vitamin A Status

September 11, 2012 updated by: USDA, Western Human Nutrition Research Center

Impact of Daily Feeding of Food Sources of Cryptoxanthin (CX) and Beta-carotene (BC) on Plasma and Breast Milk Concentrations of CX, BC, and Retinol (VA) in Lactating Women With Marginal Vitamin A Status

The study will assess the relative bioavailability and bioefficacy of cryptoxanthin (CX) and beta-carotene (BC) from food sources for increasing breast milk carotenoid and retinol concentrations in lactating Bangladeshi women.

Study Overview

Detailed Description

The specific aim is to compare the effects of orange-fleshed sweet potatoes and tangerines compared to white-fleshed sweet potatoes and vitamin A as retinyl palmitate on blood and breast milk cryptoxanthin (CX), beta-carotene (BC), and vitamin A (VA) concentrations by randomly assigning lactating Bangladeshi women to one of four treatment groups for 6 days/week for 3 weeks.

The investigators will also compare the relative vitamin A (VA) value of BC and CX from food sources by comparing the mean change in breast milk retinol concentrations of the groups that receive tangerines (CX) or orange-fleshed sweet potatoes (BC) with the mean change in breast milk retinol of the group that receives retinyl palmitate.

Study Type

Interventional

Enrollment (Actual)

140

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dhaka, Bangladesh
        • International Centre for Diarrhoeal Disease Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Healthy women in Dhaka, Bangladesh
  • Lactating women in their 2nd or 3rd month of lactation who are planning to breast-feed at least 6 months
  • Breast-feeding only one infant
  • Age range 18 to 45 years
  • Not pregnant
  • Serum retinol concentrations >0.70 umol/L and <1.10 umol/L
  • Normal concentrations of CRP (<10 mg/L)
  • At least one arm vein deemed adequate for blood collection, as evaluated by a screening nurse.
  • Willing to consume the test foods daily 6 d/wk for one month

Exclusion Criteria:

  • Health status is not compatible with the inclusion criteria, such as screening blood chemistries indicative of vitamin A deficiency.
  • Severe anemia (Hb <9 mg/dL)
  • Current pregnancy
  • Must not have known allergy to citrus fruit (tangerines or mandarin oranges) or sweet potatoes
  • Must have no obvious psychological or sociological problems-such as alcoholism, drug abuse, or severe and acute mental illness that would influence their ability to sign an inform consent agreement or to participate in study duties and activities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: 0 mg retinol
0 mg retinol activity equivalents (RAE) as white-fleshed sweet potatoes and a corn oil capsule
0 mg retinol activity equivalents (RAE) as white-fleshed sweet potatoes and a corn oil capsule
Experimental: 12 mg BC
12 mg of BC as orange-fleshed sweet potatoes and a corn oil capsule.
12 mg of BC as orange-fleshed sweet potatoes and a corn oil capsule
Experimental: 6 mg of CX
6 mg of CX as tangerines and a corn oil capsule
6 mg of CX as tangerines and a corn oil capsule
Experimental: 1.0 mg RAE
1.0 mg RAE vitamin A as retinyl palmitate in corn oil, and white-fleshed sweet potatoes
1.0 mg RAE vitamin A as retinyl palmitate in corn oil, and white-fleshed sweet potatoes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in carotenoids in serum and breast milk
Time Frame: 1 and 3 weeks
We will measure serum and breast milk beta-carotene, beta-cryptoxanthin, other carotenoids, and vitamins A and E.
1 and 3 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Dark adaptation
Time Frame: 1 and 3 weeks
Dark adaptation will be measured by the pupillary threshold (PT) test on the first and 3rd weeks of the study.
1 and 3 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Betty J Burri, PhD, WHNRC

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2010

Primary Completion (Actual)

May 1, 2011

Study Completion (Actual)

June 1, 2012

Study Registration Dates

First Submitted

August 17, 2011

First Submitted That Met QC Criteria

August 18, 2011

First Posted (Estimate)

August 19, 2011

Study Record Updates

Last Update Posted (Estimate)

September 12, 2012

Last Update Submitted That Met QC Criteria

September 11, 2012

Last Verified

September 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vitamin A Deficiency

Clinical Trials on 0 mg retinol activity equivalents

3
Subscribe